Federal Trade Commission (FTC)
FTC: We might force M&A divestitures in outside markets
Cardinal Health to pay $27m to settle FTC anti-trust charges
Feds indict ex-Acclarent execs | The week in medtech M&A
U.S. regulators OK $1.4B Sorin-Cyberonics tie-up
Zimmer extends deadline for $13B Biomet deal
Regulators deal WMGI double whammy | Regulatory news for the week of February 9, 2015
Regulators deal Wright Medical a double whammy
FTC wants more from Steris, Synergy on inversion merger
Medtronic clears all anti-trust hurdles for Covidien acquisition
Feds take a closer look at Valeant’s hostile bid for Allergan
Federal authorities are taking a closer look at Allergan’s (NYSE:AGN) ongoing battle to keep unrequited acquirer Valeant Pharmaceuticals at bay.